If you need more lookups,
subscriptions start at $34 USD/month.
Frank Torti Location
United States
Frank Torti Work
2018 -now Vant Chair and President @
2021 -now Executive Chairman @
2022 -now Executive Chairman @
2022 -2024 CEO and Chairman @ Telavant (Acquired by Roche for $7.25B)
2007 -2018 Partner @
Frank Torti Education
Harvard Business School
MBA
UNC School of Medicine
MD
Frank Torti Skills
Enterprise Software
Research
Sales
Venture Capital
Private Equity
Frank Torti Summary
Frank Torti, based in United States, is currently a Vant Chair and President at Roivant Sciences. Frank Torti brings experience from previous roles at Immunovant, Priovant Therapeutics, Telavant (Acquired by Roche for $7.25B) and New Enterprise Associates. Frank Torti holds a MBA @ Harvard Business School. With a robust skill set that includes Enterprise Software, Research, Sales, Venture Capital, Private Equity and more. Frank Torti has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Frank Torti?
Find contact details for 700 million professionals.